| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,357,063 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$69,327,006 |
|
|
| Total
Shares |
11,357,063 |
|
|
| Total
Value |
$69,327,006 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
8
|
|
Stock
price went up :
|
64
|
1
|
| Stock
price went down : |
59
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.1
|
| Percentage
Gain/Loss : |
 15.1%
|
 -143.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-22 |
123,750 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-04-13 |
4 |
B |
$6.76 |
$86,785 |
I/I |
12,832 |
157,732 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-09-28 |
4 |
B |
$9.77 |
$108,354 |
I/I |
11,085 |
158,817 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-12-14 |
4 |
B |
$10.52 |
$4,536,045 |
I/I |
431,183 |
175,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-19 |
4 |
B |
$14.65 |
$205,366 |
I/I |
14,017 |
3,614,017 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-20 |
4 |
B |
$14.49 |
$86,710 |
I/I |
5,983 |
3,620,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-11-15 |
4 |
B |
$8.03 |
$200,735 |
I/I |
25,000 |
3,645,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-20 |
4 |
B |
$9.65 |
$488,290 |
I/I |
50,600 |
3,695,600 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-28 |
4 |
B |
$12.82 |
$641,000 |
I/I |
50,000 |
3,745,600 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-19 |
4 |
B |
$10.56 |
$310,391 |
I/I |
29,400 |
3,775,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-23 |
4 |
B |
$10.29 |
$120,547 |
I/I |
11,715 |
3,786,715 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-24 |
4 |
B |
$10.15 |
$84,093 |
I/I |
8,285 |
3,795,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-25 |
4 |
B |
$9.97 |
$199,400 |
I/I |
20,000 |
3,815,000 |
1.5 |
% |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2019-12-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,091,000 |
|
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2019-12-30 |
4 |
B |
$3.97 |
$79,410 |
I/I |
20,000 |
207,500 |
1.5 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2020-01-02 |
4 |
B |
$3.90 |
$58,508 |
I/I |
15,000 |
4,918,500 |
1.5 |
- |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-24 |
4 |
B |
$16.87 |
$5,061,000 |
I/I |
300,000 |
2,408,472 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-30 |
4 |
B |
$16.00 |
$800,000 |
I/I |
50,000 |
2,458,472 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-04 |
4 |
B |
$6.50 |
$42,621 |
I/I |
6,557 |
100,557 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-17 |
4 |
B |
$6.98 |
$63,644 |
I/I |
9,118 |
101,647 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-11-18 |
4 |
B |
$6.98 |
$106,130 |
I/I |
15,206 |
102,647 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-16 |
4 |
B |
$6.41 |
$48,485 |
I/I |
7,563 |
103,710 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-17 |
4 |
B |
$6.60 |
$18,414 |
I/I |
2,790 |
104,200 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-20 |
4 |
B |
$6.49 |
$4,562 |
I/I |
703 |
2,496,209 |
1.42 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-23 |
4 |
B |
$6.60 |
$8,580 |
I/I |
1,300 |
105,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2021-12-27 |
4 |
B |
$6.53 |
$239,713 |
I/I |
36,700 |
110,000 |
1.5 |
% |
|
160 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
